Understanding the biology of relapsed ependymoma brain tumours to help improve treatments
Deciphering the New Molecular Landscape in Paediatric Recurrent Ependymoma: Implications for Molecular Targeted Therapy
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Deciphering the New Molecular Landscape in Paediatric Recurrent Ependymoma: Implications for Molecular Targeted Therapy
Teenagers and young adults with primary CNS cancers: a systematic biological characterisation
Minimal residual disease detection of ependymoma by microRNA biomarker profile evaluation as part of SIOP Ependymoma II trial
Molecular pathophysiology of histone G34R mutated childhood brain tumours: towards the development of novel targeted therapies
Improving the diagnosis of children’s brain tumours by Functional Radiomics
Investigating the arginine auxotrophy of paediatric brain tumours
Comprehensive molecular characterization of paediatric spinal ependymomas
Molecular profiling of relapsing craniopharyngioma
Brain distribution models to select polymer-delivered drugs for the treatment of childhood brain cancers